Which has stronger valuation and earnings, MDXH or CCLD?

CareCloud has higher revenue and earnings than MDxHealth. MDxHealth is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio MDxHealth $110.97M 0.24 -$33.52M -$0.65 N/A CareCloud $120.50M 0.81 $10.80M $0.11 20.91

Is MDXH or CCLD more profitable?

CareCloud has a net margin of 7.87% compared to MDxHealth's net margin of -29.90%. CareCloud's return on equity of 24.05% beat MDxHealth's return on equity. Company Net Margins Return on Equity Return on Assets MDxHealth -29.90% -1,078.01% -22.51% CareCloud 7.87% 24.05% 16.38%

Is ZEPP or MDXH more profitable?

Zepp Health has a net margin of -14.70% compared to MDxHealth's net margin of -29.90%. Zepp Health's return on equity of -15.64% beat MDxHealth's return on equity. Company Net Margins Return on Equity Return on Assets Zepp Health -14.70% -15.64% -6.03% MDxHealth -29.90% -1,078.01% -22.51%

Is PIII or MDXH more profitable?

P3 Health Partners has a net margin of -8.57% compared to MDxHealth's net margin of -29.90%. P3 Health Partners' return on equity of -302.33% beat MDxHealth's return on equity. Company Net Margins Return on Equity Return on Assets P3 Health Partners -8.57% -302.33% -19.99% MDxHealth -29.90% -1,078.01% -22.51%

Is OM or MDXH more profitable?

MDxHealth has a net margin of -29.90% compared to Outset Medical's net margin of -63.65%. Outset Medical's return on equity of -56.13% beat MDxHealth's return on equity. Company Net Margins Return on Equity Return on Assets Outset Medical -63.65% -56.13% -27.45% MDxHealth -29.90% -1,078.01% -22.51%

Which has preferable valuation and earnings, MDXH or LUNG?

MDxHealth has higher revenue and earnings than Pulmonx. Pulmonx is trading at a lower price-to-earnings ratio than MDxHealth, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio MDxHealth $110.97M 0.24 -$33.52M -$0.65 N/A Pulmonx $90.50M 0.64 -$54M -$1.30 N/A

Is MDXH or LUNG more profitable?

MDxHealth has a net margin of -29.90% compared to Pulmonx's net margin of -60.09%. Pulmonx's return on equity of -92.94% beat MDxHealth's return on equity. Company Net Margins Return on Equity Return on Assets MDxHealth -29.90% -1,078.01% -22.51% Pulmonx -60.09% -92.94% -39.80%

MDxHealth (MDXH) Competitors

$0.54 0.00 (0.00%)

Closing price 06/12/2026 04:00 PM Eastern

Extended Trading

$0.55 +0.01 (+1.25%)

As of 06/12/2026 07:34 PM Eastern

Compare

MDXH vs. CCLD, ZEPP, PIII, OM, and LUNG

Should you buy MDxHealth stock or one of its competitors? MarketBeat compares MDxHealth with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with MDxHealth include CareCloud (CCLD), Zepp Health (ZEPP), P3 Health Partners (PIII), Outset Medical (OM), and Pulmonx (LUNG). These companies are all part of the "medical info sys" industry.

How does MDxHealth compare to CareCloud?

MDxHealth (NASDAQ:MDXH) and CareCloud (NASDAQ:CCLD) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, media sentiment, risk, institutional ownership, dividends, profitability, valuation and analyst recommendations.

CareCloud has a net margin of 7.87% compared to MDxHealth's net margin of -29.90%. CareCloud's return on equity of 24.05% beat MDxHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MDxHealth	-29.90%	-1,078.01%	-22.51%
CareCloud	7.87%	24.05%	16.38%

CareCloud has higher revenue and earnings than MDxHealth. MDxHealth is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MDxHealth	$110.97M	0.24	-$33.52M	-$0.65	N/A
CareCloud	$120.50M	0.81	$10.80M	$0.11	20.91

10.2% of CareCloud shares are held by institutional investors. 1.7% of MDxHealth shares are held by insiders. Comparatively, 14.8% of CareCloud shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

MDxHealth currently has a consensus price target of $4.63, suggesting a potential upside of 753.01%. CareCloud has a consensus price target of $3.25, suggesting a potential upside of 41.30%. Given MDxHealth's stronger consensus rating and higher possible upside, equities analysts plainly believe MDxHealth is more favorable than CareCloud.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MDxHealth	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
CareCloud	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33

In the previous week, MDxHealth had 1 more articles in the media than CareCloud. MarketBeat recorded 2 mentions for MDxHealth and 1 mentions for CareCloud. MDxHealth's average media sentiment score of 1.43 beat CareCloud's score of 0.94 indicating that MDxHealth is being referred to more favorably in the media.

Company	Overall Sentiment
MDxHealth	Positive
CareCloud	Positive

MDxHealth has a beta of 1.36, indicating that its stock price is 36% more volatile than the broader market. Comparatively, CareCloud has a beta of 1.51, indicating that its stock price is 51% more volatile than the broader market.

Summary

CareCloud beats MDxHealth on 11 of the 16 factors compared between the two stocks.

How does MDxHealth compare to Zepp Health?

Zepp Health (NYSE:ZEPP) and MDxHealth (NASDAQ:MDXH) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, earnings, analyst recommendations, media sentiment, institutional ownership, dividends, valuation and risk.

In the previous week, Zepp Health had 6 more articles in the media than MDxHealth. MarketBeat recorded 8 mentions for Zepp Health and 2 mentions for MDxHealth. MDxHealth's average media sentiment score of 1.43 beat Zepp Health's score of 0.34 indicating that MDxHealth is being referred to more favorably in the news media.

Company	Overall Sentiment
Zepp Health	Neutral
MDxHealth	Positive

MDxHealth has lower revenue, but higher earnings than Zepp Health. Zepp Health is trading at a lower price-to-earnings ratio than MDxHealth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zepp Health	$258.90M	0.27	-$40.07M	-$2.52	N/A
MDxHealth	$110.97M	0.24	-$33.52M	-$0.65	N/A

Zepp Health has a beta of 1.78, suggesting that its share price is 78% more volatile than the broader market. Comparatively, MDxHealth has a beta of 1.36, suggesting that its share price is 36% more volatile than the broader market.

52.6% of Zepp Health shares are owned by institutional investors. 36.0% of Zepp Health shares are owned by insiders. Comparatively, 1.7% of MDxHealth shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Zepp Health has a net margin of -14.70% compared to MDxHealth's net margin of -29.90%. Zepp Health's return on equity of -15.64% beat MDxHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zepp Health	-14.70%	-15.64%	-6.03%
MDxHealth	-29.90%	-1,078.01%	-22.51%

Zepp Health presently has a consensus target price of $56.28, suggesting a potential upside of 1,103.59%. MDxHealth has a consensus target price of $4.63, suggesting a potential upside of 753.01%. Given Zepp Health's higher probable upside, analysts plainly believe Zepp Health is more favorable than MDxHealth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zepp Health	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
MDxHealth	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

Zepp Health beats MDxHealth on 10 of the 16 factors compared between the two stocks.

How does MDxHealth compare to P3 Health Partners?

P3 Health Partners (NASDAQ:PIII) and MDxHealth (NASDAQ:MDXH) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, media sentiment, risk, institutional ownership, valuation, earnings and analyst recommendations.

7.8% of P3 Health Partners shares are owned by institutional investors. 10.9% of P3 Health Partners shares are owned by company insiders. Comparatively, 1.7% of MDxHealth shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

P3 Health Partners has a net margin of -8.57% compared to MDxHealth's net margin of -29.90%. P3 Health Partners' return on equity of -302.33% beat MDxHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
P3 Health Partners	-8.57%	-302.33%	-19.99%
MDxHealth	-29.90%	-1,078.01%	-22.51%

P3 Health Partners has a beta of 1.57, meaning that its stock price is 57% more volatile than the broader market. Comparatively, MDxHealth has a beta of 1.36, meaning that its stock price is 36% more volatile than the broader market.

In the previous week, P3 Health Partners had 1 more articles in the media than MDxHealth. MarketBeat recorded 3 mentions for P3 Health Partners and 2 mentions for MDxHealth. MDxHealth's average media sentiment score of 1.43 beat P3 Health Partners' score of 0.96 indicating that MDxHealth is being referred to more favorably in the news media.

Company	Overall Sentiment
P3 Health Partners	Positive
MDxHealth	Positive

MDxHealth has lower revenue, but higher earnings than P3 Health Partners. MDxHealth is trading at a lower price-to-earnings ratio than P3 Health Partners, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
P3 Health Partners	$1.46B	0.06	-$147.95M	-$38.60	N/A
MDxHealth	$110.97M	0.24	-$33.52M	-$0.65	N/A

P3 Health Partners presently has a consensus price target of $14.00, suggesting a potential upside of 14.47%. MDxHealth has a consensus price target of $4.63, suggesting a potential upside of 753.01%. Given MDxHealth's stronger consensus rating and higher probable upside, analysts plainly believe MDxHealth is more favorable than P3 Health Partners.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
P3 Health Partners	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
MDxHealth	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

P3 Health Partners beats MDxHealth on 9 of the 16 factors compared between the two stocks.

How does MDxHealth compare to Outset Medical?

Outset Medical (NASDAQ:OM) and MDxHealth (NASDAQ:MDXH) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, media sentiment, analyst recommendations, valuation, risk and institutional ownership.

MDxHealth has a net margin of -29.90% compared to Outset Medical's net margin of -63.65%. Outset Medical's return on equity of -56.13% beat MDxHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Outset Medical	-63.65%	-56.13%	-27.45%
MDxHealth	-29.90%	-1,078.01%	-22.51%

MDxHealth has lower revenue, but higher earnings than Outset Medical. Outset Medical is trading at a lower price-to-earnings ratio than MDxHealth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Outset Medical	$119.48M	0.70	-$81.65M	-$4.16	N/A
MDxHealth	$110.97M	0.24	-$33.52M	-$0.65	N/A

In the previous week, Outset Medical had 1 more articles in the media than MDxHealth. MarketBeat recorded 3 mentions for Outset Medical and 2 mentions for MDxHealth. MDxHealth's average media sentiment score of 1.43 beat Outset Medical's score of 0.62 indicating that MDxHealth is being referred to more favorably in the news media.

Company	Overall Sentiment
Outset Medical	Positive
MDxHealth	Positive

Outset Medical presently has a consensus price target of $10.00, indicating a potential upside of 122.72%. MDxHealth has a consensus price target of $4.63, indicating a potential upside of 753.01%. Given MDxHealth's stronger consensus rating and higher probable upside, analysts plainly believe MDxHealth is more favorable than Outset Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Outset Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
MDxHealth	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

Outset Medical has a beta of 1.95, indicating that its stock price is 95% more volatile than the broader market. Comparatively, MDxHealth has a beta of 1.36, indicating that its stock price is 36% more volatile than the broader market.

Summary

MDxHealth beats Outset Medical on 9 of the 14 factors compared between the two stocks.

How does MDxHealth compare to Pulmonx?

MDxHealth (NASDAQ:MDXH) and Pulmonx (NASDAQ:LUNG) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, valuation, media sentiment, analyst recommendations, institutional ownership and dividends.

MDxHealth has a beta of 1.36, meaning that its share price is 36% more volatile than the broader market. Comparatively, Pulmonx has a beta of 0.28, meaning that its share price is 72% less volatile than the broader market.

MDxHealth currently has a consensus target price of $4.63, indicating a potential upside of 753.01%. Pulmonx has a consensus target price of $5.58, indicating a potential upside of 307.54%. Given MDxHealth's stronger consensus rating and higher possible upside, research analysts plainly believe MDxHealth is more favorable than Pulmonx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MDxHealth	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
Pulmonx	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43

MDxHealth has a net margin of -29.90% compared to Pulmonx's net margin of -60.09%. Pulmonx's return on equity of -92.94% beat MDxHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MDxHealth	-29.90%	-1,078.01%	-22.51%
Pulmonx	-60.09%	-92.94%	-39.80%

MDxHealth has higher revenue and earnings than Pulmonx. Pulmonx is trading at a lower price-to-earnings ratio than MDxHealth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MDxHealth	$110.97M	0.24	-$33.52M	-$0.65	N/A
Pulmonx	$90.50M	0.64	-$54M	-$1.30	N/A

In the previous week, MDxHealth had 1 more articles in the media than Pulmonx. MarketBeat recorded 2 mentions for MDxHealth and 1 mentions for Pulmonx. Pulmonx's average media sentiment score of 1.87 beat MDxHealth's score of 1.43 indicating that Pulmonx is being referred to more favorably in the news media.

Company	Overall Sentiment
MDxHealth	Positive
Pulmonx	Very Positive

91.0% of Pulmonx shares are owned by institutional investors. 1.7% of MDxHealth shares are owned by insiders. Comparatively, 6.8% of Pulmonx shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

MDxHealth beats Pulmonx on 10 of the 15 factors compared between the two stocks.

Get MDxHealth News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MDXH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MDXH vs. The Competition

Export

Metric	MDxHealth	MEDICAL INFO SYS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$26.84M	$1.50B	$6.52B	$12.05B
Dividend Yield	N/A	N/A	2.67%	5.66%
P/E Ratio	-0.83	77.55	24.00	24.42
Price / Sales	0.24	6.92	515.84	118.72
Price / Cash	N/A	22.98	27.48	37.92
Price / Book	-2.26	4.82	10.60	6.82
Net Income	-$33.52M	-$54.76M	$3.57B	$337.56M
7 Day Performance	-0.70%	-1.67%	0.59%	1.16%
1 Month Performance	-39.28%	0.13%	1.54%	3.16%
1 Year Performance	-72.89%	-6.47%	25.41%	30.60%

MDxHealth Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MDXH MDxHealth	4.114 of 5 stars	$0.54 flat	$4.63 +753.0%	-72.9%	$26.84M	$110.97M	N/A	300	Positive News Short Interest Decrease Gap Up
CCLD CareCloud	4.0143 of 5 stars	$2.39 +0.8%	$3.25 +36.0%	+11.1%	$100.71M	$120.50M	21.73	3,650
ZEPP Zepp Health	2.6213 of 5 stars	$4.39 -29.0%	$56.28 +1,183.5%	+102.9%	$90.72M	$258.90M	N/A	1,230	Earnings Report High Trading Volume
PIII P3 Health Partners	2.3084 of 5 stars	$12.54 +2.4%	$14.00 +11.6%	+89.9%	$88.75M	$1.46B	N/A	500	Short Interest Decrease Gap Up
OM Outset Medical	2.5257 of 5 stars	$4.69 +8.6%	$10.00 +113.2%	-77.5%	$80.08M	$119.48M	N/A	520	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:MDXH) was last updated on 6/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

MDxHealth (MDXH) Competitors

MDXH vs. CCLD, ZEPP, PIII, OM, and LUNG

How does MDxHealth compare to CareCloud?

Summary

How does MDxHealth compare to Zepp Health?

Summary

How does MDxHealth compare to P3 Health Partners?

Summary

How does MDxHealth compare to Outset Medical?

Summary

How does MDxHealth compare to Pulmonx?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MDXH vs. The Competition

MDxHealth Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

MDxHealth (MDXH) Competitors

MDXH vs. CCLD, ZEPP, PIII, OM, and LUNG

How does MDxHealth compare to CareCloud?

Is MDXH or CCLD more profitable?

Which has stronger valuation and earnings, MDXH or CCLD?

Do insiders and institutionals hold more shares of MDXH or CCLD?

Do analysts rate MDXH or CCLD?

Does the media prefer MDXH or CCLD?

Which has more volatility & risk, MDXH or CCLD?

Summary

How does MDxHealth compare to Zepp Health?

Does the media refer more to ZEPP or MDXH?

Which has preferable valuation & earnings, ZEPP or MDXH?

Which has more risk and volatility, ZEPP or MDXH?

Do institutionals & insiders believe in ZEPP or MDXH?

Is ZEPP or MDXH more profitable?

Do analysts rate ZEPP or MDXH?

Summary

How does MDxHealth compare to P3 Health Partners?

Do institutionals and insiders hold more shares of PIII or MDXH?

Is PIII or MDXH more profitable?

Which has more volatility & risk, PIII or MDXH?

Does the media favor PIII or MDXH?

Which has preferable earnings & valuation, PIII or MDXH?

Do analysts recommend PIII or MDXH?

Summary

How does MDxHealth compare to Outset Medical?

Is OM or MDXH more profitable?

Which has stronger valuation & earnings, OM or MDXH?

Does the media favor OM or MDXH?

Do analysts rate OM or MDXH?

Which has more volatility & risk, OM or MDXH?

Summary

How does MDxHealth compare to Pulmonx?

Which has more volatility and risk, MDXH or LUNG?

Do analysts rate MDXH or LUNG?

Is MDXH or LUNG more profitable?

Which has preferable valuation and earnings, MDXH or LUNG?

Does the media refer more to MDXH or LUNG?

Do insiders & institutionals have more ownership in MDXH or LUNG?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MDXH vs. The Competition

MDxHealth Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools